Ladenburg Thalmann Downgraded Micromet (MITI) Following Amgen Bid
Tweet
Share
E-mailGet Alerts MITI Hot Sheet
Price: $0.45 --0%
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Join SI Premium – FREE
Ladenburg Thalmann's Juan Sachez downgraded shares of Micromet (NASDAQ: MITI) Thursday following news Amgen has offered to acquire the company in a $1.16 billion deal. Micromet shares are up nearly 32 percent this afternoon.
Sanchez now rates Micromet shares a Neutral, down from Buy previously. The analyst's price target was raised from $8 to $11.
For an analyst ratings summary and ratings history on Micromet click here. For more ratings news on Micromet click here.
Sanchez now rates Micromet shares a Neutral, down from Buy previously. The analyst's price target was raised from $8 to $11.
For an analyst ratings summary and ratings history on Micromet click here. For more ratings news on Micromet click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Genuity Downgrades Antofagasta Plc. (ANTO:LN) (ANFGF) to Hold
- Morgan Stanley Downgrades Envista Holdings Corp. (NVST) to Equalweight
- Morgan Stanley Downgrades Carrefour SA (CA:FP) (CRRFY) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Ladenburg Thalmann Financial Services, Amgen/MicrometSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
